PINC Research has downgraded Ranbaxy Laboratories to `Sell` with a price target of Rs 355 as against the current market price (CMP) of Rs 475 in... ...
http://www.myiris.com/newsCentre/storyShow.php?fileR=20120127141701717&dir=2012/01/27&source=rss